Johnson Controls (JCI)
NYSEIndustrialsConstruction MaterialsSnapshot 2026-09-04
$144.94+1.91%
Close 2026-09-04 · 1-day change
NYSEIndustrialsConstruction MaterialsSnapshot 2026-09-04
Broken: Recent financial performance freshly dropped to the bottom half of its industry.
Johnson Controls grows sales about 6% a year. Profit margin stays near 50%. Earnings per share rise to about $4.85 in fiscal 2026. The company beats earnings estimates consistently and buys back shares.
Growth could slow below 6% if demand weakens. Profit margins might compress from 50%. Leadership changes could disrupt execution. Valuation is high compared to peers.
The price is about 22% above our fair value near $116 and 32% below the Street median target. Analysts expect about 9% revenue growth, slightly above our 6% target. We see valuation as stretched but justified by steady growth.
Breaks if: EPS falls below $4.85 in FY26
Sustain operating leverage around 50% in fiscal 2026 to enhance profitability through efficient cost management and revenue growth.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story in the industrial sector. The current thesis state is weakened due to recent performance dropping within its industry and elevated valuation concerns.
The market appears to be pricing in a fragile situation, with an expensive valuation and weak execution quality. There is an expectations gap indicating that the market may be overly optimistic about future performance.
Fundamentals are on track for adjusted EPS and operating leverage, but organic sales growth has shown mixed results. Near-term risks remain moderate, with a low probability of missing guidance, but recent history raises caution.
The thesis hinges on the performance of sector bellwethers like MAS, CSL, and OC, which could influence JCI's trajectory. Additionally, any reversal in guidance from JCI could significantly impact credibility and investor sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. Recent financial performance dropped from the top half to the bottom half of its industry. This change indicates that the reason to own JCI has weakened. However, the company posted better-than-expected sales in Q2 CY2026, supporting its sales growth objective.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 4 of last 4 quarters. Operating leverage guidance for fiscal 2026 has consistently targeted approximately 50%. The company reported adjusted Segment EBITA margin improvements and margin expansion across key segments in Q1-Q3 2026, indicating delivery consistent with this priority.
“The Company initiated fiscal 2026 fourth quarter continuing operations guidance: Operating leverage of 45% to 50%”
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Operating leverage of 45% to 50% (previously ~50%)”
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Operating leverage of ~50% (unchanged)”
“The Company initiated fiscal 2026 full year continuing operations guidance: Operating leverage of ~50%”
Breaks if: Significant leadership disruption or strategic missteps occur
Breaks if: operating leverage falls significantly below 50% in FY26
Sustain operating leverage around 50% in fiscal 2026 to enhance profitability through efficient cost management and revenue growth.
Stated as a priority in 4 of last 4 quarters. Operating leverage guidance for fiscal 2026 has consistently targeted approximately 50%. The company reported adjusted Segment EBITA margin improvements and margin expansion across key segments in Q1-Q3 2026, indicating delivery consistent with this priority.
“The Company initiated fiscal 2026 fourth quarter continuing operations guidance: Operating leverage of 45% to 50%”
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Operating leverage of 45% to 50% (previously ~50%)”
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Operating leverage of ~50% (unchanged)”
“The Company initiated fiscal 2026 full year continuing operations guidance: Operating leverage of ~50%”
Breaks if: organic sales growth falls below 6% in FY26
Maintain and grow organic sales by approximately 6% in fiscal 2026, reflecting sustained demand and market expansion.
Stated as a priority in 4 of last 4 quarters. Fiscal 2026 guidance consistently targets organic sales growth around 6%, with Q3 guidance raising it to ~8%. Actual reported organic sales growth in Q3 2026 was 10%, showing delivery above initial guidance and positive trajectory.
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Organic sales growth of ~8% (previously up ~6%)”
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Organic sales growth of ~6% (previously up mid-single digits)”
“The Company's fiscal 2026 full year continuing operations guidance is as follows: Organic sales growth of mid-single digits (unchanged)”
“The Company initiated fiscal 2026 full year continuing operations guidance: Organic sales growth of mid-single digits”
Over the next 1 to 3 years, JCI faces challenges that could impact its performance, particularly if sector trends shift unfavorably. Not investment advice.